• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.

作者信息

Johnson A P, Warner M, Parsons T

出版信息

Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):622-3. doi: 10.1007/BF02447932.

DOI:10.1007/BF02447932
PMID:9323481
Abstract
摘要

相似文献

1
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.格帕沙星对肺炎链球菌呼吸道分离株的活性。
Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):622-3. doi: 10.1007/BF02447932.
2
In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.格帕沙星及其他25种抗菌药物对肺炎链球菌的体外活性：与青霉素耐药性的相关性
Clin Ther. 1998 Nov-Dec;20(6):1179-90. doi: 10.1016/s0149-2918(98)80113-6.
3
Quinolones and pneumococci.喹诺酮类药物与肺炎球菌。
J Antimicrob Chemother. 2000 May;45(5):709-10. doi: 10.1093/jac/45.5.709.
4
Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.通过时间杀菌法比较格帕沙星与其他药物的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1998 May;42(5):1263-5. doi: 10.1128/AAC.42.5.1263.
5
Susceptibility testing of Streptococcus pneumoniae and Viridans streptococcal isolates against: quinolones, oxazolidinones and glycopeptides.
Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):286-90.
6
The activity of grepafloxacin against respiratory pathogens in the UK.格帕沙星在英国针对呼吸道病原体的活性。
J Antimicrob Chemother. 1997 Dec;40 Suppl A:27-30. doi: 10.1093/jac/40.suppl_1.27.
7
In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens.司帕沙星与现有抗微生物药物对呼吸道病原体的体外活性比较。
J Antimicrob Chemother. 1996 May;37 Suppl A:1-18. doi: 10.1093/jac/37.suppl_a.1.
8
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.司帕沙星，一种用于治疗肺炎链球菌呼吸道感染的新一代氟喹诺酮类药物。
Drugs. 1995;49 Suppl 2:420-2. doi: 10.2165/00003495-199500492-00121.
9
Respiratory pathogens: assessing resistance patterns in Europe and the potential role of grepafloxacin as treatment of patients with infections caused by these organisms.呼吸道病原体：评估欧洲的耐药模式以及格帕沙星在治疗这些病原体引起的感染患者中的潜在作用。
J Antimicrob Chemother. 2000 Mar;45:1-8. doi: 10.1093/jac/45.suppl_2.1.
10
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.曲伐沙星对1997 - 1998年呼吸道感染季节分离出的3049株肺炎链球菌的抗菌活性比较
Diagn Microbiol Infect Dis. 1998 Oct;32(2):119-26. doi: 10.1016/s0732-8893(98)00072-8.

本文引用的文献

1
Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.1990年和1995年英格兰和威尔士肺炎球菌抗生素耐药性及血清型的流行情况：观察性调查结果
BMJ. 1996 Jun 8;312(7044):1454-6. doi: 10.1136/bmj.312.7044.1454.
2
Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.CP99,219与DU-6859a、环丙沙星、氧氟沙星、左氧氟沙星、洛美沙星、妥舒沙星、司帕沙星及格帕沙星对青霉素敏感和耐药肺炎球菌的活性比较。
J Antimicrob Chemother. 1995 Jan;35(1):230-2. doi: 10.1093/jac/35.1.230.
3
Antimicrobial resistance in Streptococcus pneumoniae: an overview.
肺炎链球菌中的抗菌药物耐药性：概述
Clin Infect Dis. 1992 Jul;15(1):77-83. doi: 10.1093/clinids/15.1.77.
4
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):372-81. doi: 10.1007/BF01962081.
5
In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.新型喹诺酮OPC-17116的体外和体内抗菌活性
Antimicrob Agents Chemother. 1992 Mar;36(3):573-9. doi: 10.1128/AAC.36.3.573.